The Lupus Research Alliance (LRA) is encouraged by the recent study, “Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus”, funded in part by the LRA and published in the journal Nature, that identified a molecular pathway that promotes an imbalance of T cells leading to an overactive immune response in lupus. […] READ MORE
New York, NY, February 28. The Lupus Research Alliance (LRA) is pleased to announce the recent recipients of the Lupus Mechanisms and Targets Award (LMTA), whose research will investigate molecular pathways or targets that will lead to new or improved therapies for individuals with systemic lupus erythematosus (SLE). The LMTA provides investigators up to $600,000 […] READ MORE
Research Will Explore How Ancient Viral Remnants in Our DNA Trigger Lupus NEW YORK, NY – January 30. The Lupus Research Alliance (LRA) is pleased to grant the 2023 Dr. William E. Paul Distinguished Innovator Award (DIA) to Akiko Iwasaki, Ph.D., Sterling Professor of Immunobiology at the Yale School of Medicine. Dr. Iwasaki will investigate […] READ MORE
June 23, 2022 The Lupus Research Alliance (LRA) is pleased to award its 2022 Lupus Insight Prize (LIP) to Akiko Iwasaki, PhD, for her discovery of the link between endogenous retroviruses and systemic lupus erythematosus (SLE). The award was presented to Dr. Iwasaki at the 22nd Annual Meeting of the Federation of Clinical Immunology Societies […] READ MORE
NEW YORK, NY, June 9, 2022. The Lupus Research Alliance (LRA), the world’s leading private funder of lupus research, today announced inaugural recipients of Career Development and Postdoctoral Awards to Promote Diversity in Lupus Research. The Diversity in Lupus Research Award funding mechanisms aim to address underrepresentation of minorities in the scientific research profession. Lupus […] READ MORE
Updated March, 2022 Developing safe and effective treatments for lupus nephritis has been an urgent and long-standing goal in the lupus community. As the leading private funding agency for lupus research, the LRA and its legacy organizations have dedicated significant focus and resources towards addressing this continued challenge, awarding over 40 grants to address this […] READ MORE
January 27, 2022 NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and its clinical affiliate Lupus Therapeutics (LT) announced two major initiatives to address underrepresentation of minorities in clinical trials and in the scientific research profession: Project CHANGE by LT and the Diversity in Lupus Research Program. The organization has tackled these […] READ MORE
The Lupus Research Alliance supports the full range of research from fundamental through translational and clinical studies. Most recently, the organization awarded six Novel Research Grants and seven Target Identification in Lupus (TIL) grants. PROMISING NOVEL GRANT AWARDS: The Lupus Research Alliance supports game-changing lupus research, and our Novel Research Grant program is exploring lupus […] READ MORE
Sept. 7, 2017. Grantees of our Target Identification in Lupus (TIL) program are remarkable scientific investigators whose ingenuity and determination are bringing new insights to lupus research. The Lupus Research Alliance congratulates each of these brilliant researchers in their quest to expand our understanding of lupus and ways to defeat it: Kerstin Nundel, PhD University […] READ MORE
July 28, 2017. The Lupus Research Alliance is delighted to announce the recipients of our 2017 Novel Research Grants. These ten grantees continue a commitment to bold and innovative research that aims to discover safe, effective treatments and a cure for lupus. Mridu Acharya, PhD Benaroya Research Institute at Virginia Mason Dr. Acharya is investigating the […] READ MORE
10 New Grants, 10 New Insights The path to safe and effective treatments and ultimately a cure lies in bold, pioneering research. The Lupus Research Alliance Novel Research Grants, the proven platform for innovation, make discovery and scientific progress possible. “Standing on a 16-year foundation of documented success, the Novel Research Grants bring new insight […] READ MORE